Effects of flavonoids on rat aortic smooth muscle contractility: Structure-activity relationships

General Pharmacology

Volumn 27, Issue 2, 1996, Pages 273-277

  Herrera, María Dolores ^a   Zarzuelo, Antonio ^b   Jiménez, José ^b   Marhuenda, Elisa ^a   Duarte, Juan ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

aorta; flavonoid; rat

Indexed keywords

CALCIUM; CHRYSIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; FLAVANONE; FLAVONOID; GENISTEIN; HESPERETIN; ISOPRENALINE; MORIN; MYRICETIN; NARINGENIN; NITROPRUSSIDE SODIUM; NORADRENALIN; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHLORIDE; PROTEIN KINASE C;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; STRUCTURE ACTIVITY RELATION; THORACIC AORTA; VASODILATATION;

EID: 0011253580     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02010-1     Document Type: Article

References (25)

1. Ahn H., Karaki H. and Urakawa N. (1988) Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle. Br. J. Pharmac. 93, 267-274.
2. Akiyama T., Ishida J., Nakagawa H., Ogawara S., Watanabe S., Itoh N., Shibuya M. and Fukami Y. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262, 5592-5595.
3. Beretz A., Stoclet J. and Anton R. (1980) Inhibition of isolated rat aorta contraction by flavonoids. Possible correlation with cyclic AMP phosphodiesterase inhibition. Planta Medica 39, 236-237.
4. Berger M. E., Golub M. S., Chang C.T., Al-Kharouf J. A., Nyby M. D., Hori M., Brickman A. S. and Tuck M. L. (1992) Flavonoid potentiation of contractile responses in rat blood vessels. J. Pharmacol. Exp. Ther. 263, 78-83.
5. Bolton T. (1979) Mechanisms of action of transmitters and others substances on smooth muscles. Physiol. Rev. 59, 606-718.
6. Chen Q. and Van Breemen C. (1993) The superficial buffer barrier in venous smooth muscle: sarcoplasmic reticulum refilling and unloading. Br. J. Pharmac. 109, 336-343.
7. 45Ca uptake in isolated rat vascular smooth muscle. Gen. Pharmac. 23, 601-606.
8. Duarte J., Pérez-Vizcaino F., Zarzuelo A., Jiménez J. and Tamargo J. (1993a) Vasodilator effects of quercetin in isolated rat vascular smooth muscle. Eur. J. Pharmacol. 239, 1-7.
9. Duarte J., Pérez-Vizcaino F., Utrilla P., Jiménez J., Tamargo J. and Zarzuelo A. (1993b) Vasodilatory effects of flavonoids in rat aortic smooth muscle. Structure-activity relationships. Gen. Pharmac. 24, 857-862.
10. Duarte J., Pérez-Vizcaino F., Zarzuelo A., Jiménez J. and Tamargo J. (1994) Inhibitory effects of quercetin and staurosporine on phasic contractions in rat vascular smooth muscle. Eur. J. Pharmac. 262, 149-156.
11. Ferriola P. C., Cody V. and Middleton E. Jr. (1989) Protein kinase C inhibition by flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmac. 38, 1617-1624.
12. Gabor M. (1986) Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships, p. 471. Alan R. Liss, New York.
13. Hardman J. G. (1984) Cyclic nucleotides and regulation of vascular smooth muscle. J. Cardiovasc. Pharmac. 6, S639-S645.
14. Jiang M. J. and Morgan K. G. (1987) Intracellular calcium level in phorbol ester-induced contractions of vascular muscle. Am. J. Physiol. 253, H1365-H1371.
15. 2+ localization and sensitivity in vascular smooth muscle. Trends Pharmac. Sci. 10, 320-325.
16. Ko F., Huang T. and Teng C. (1991) Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta. Biochim. Biophys. Acta 1115, 69-74.
17. Laniyonu A., Saifeddine M., Ahman S. and Hollenberg M. D. (1994) Regulation of vascular and gastric smooth muscle contractility by pervanadate. Br. J. Pharmac. 113, 403-410.
18. Lorenz K. and Wells J. (1983) Potentiation of the effects of sodium nitroprusside and isoproterenol by selective phosphodiesterase inhibitors. Mol. Pharmac. 23, 424-430.
19. Middleton E. Jr. (1984) The flavonoids. Trends Biol. Sci. 5, 335-338.
20. Pathak K., Pathak A. and Singla A. (1991) Flavonoids as medical agents. Fitoterapia 62, 371-389.
21. Putney J. W. Jr. (1990) Capacitative calcium entry revisited. Cell Calcium 7, 1-12.
22. Rasmussen H., Takuwa Y. and Park S. (1987) Protein kinase C in the regulation of smooth muscles contraction. FASEB J. 1, 177-185.
23. Schoeffter P., Lugnier C., Demesy-Waeldele F. and Stoclet J. C. (1987) Role of cycle AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Biochem. Pharmac. 36, 3965-3972.
24. 2+ pump. Kinetics and structure-function relationships. Biochem. Pharmac. 41, 669-675.
25. 2+ movements in rat isolated aorta. J. Pharm. Pharmac. 43, 46-48.